Related Experiment Video

Updated: Jul 19, 2026

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
06:30

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats

Published on: September 11, 2018

The sympathetic drive after acute myocardial infarction in hypertensive patients

Andrew J Hogarth1, Alan F Mackintosh, David A S G Mary

  • 1The Department of Cardiology, St James's University Hospital, Leeds, UK. hogarth2003@yahoo.co.uk

American Journal of Hypertension
|October 10, 2006
PubMed

Insights

Following acute myocardial infarction (AMI), hypertensive patients exhibit prolonged sympathetic nervous system activation compared to normotensive individuals. This sustained sympathetic hyperactivity may contribute to the worse prognosis observed in hypertensive patients after AMI.

Area of Science:

  • Cardiovascular Physiology
  • Hypertension Research
  • Myocardial Infarction Studies

Background:

  • Sympathetic activation is a known risk factor in hypertension (HT) and acute myocardial infarction (AMI).
  • Patients with both conditions (AMI-HT) face higher cardiovascular risks than those without antecedent HT (AMI-NT).

Purpose of the Study:

  • To investigate if sympathetic activation and its duration are elevated after AMI in patients with pre-existing hypertension compared to normotensive individuals.

Main Methods:

  • Muscle sympathetic nerve activity (MSNA) was measured in 68 subjects across four groups: AMI-HT, AMI-NT, HT, and normotensive (NT).
  • MSNA was assessed using multiunit (m-MSNA) and single-unit (s-MSNA) burst frequencies.
  • Measurements in AMI groups were taken shortly after infarction and at 3-month intervals until MSNA normalized.

Main Results:

  • Patients with AMI-HT showed significantly higher s-MSNA (99 ± 3.5 impulses/100 cardiac beats) compared to AMI-NT (84 ± 2.8 impulses/100 cardiac beats).
  • s-MSNA hyperactivity persisted in AMI-HT throughout the 9-month follow-up, returning to baseline HT and NT levels later.
  • Similar trends were observed for m-MSNA.

Conclusions:

  • Acute myocardial infarction exacerbates sympathetic hyperactivity in hypertensive patients, with elevated MSNA levels persisting for at least 6 months longer than in normotensive individuals.
  • This prolonged sympathetic activation in AMI-HT could be a key factor contributing to their poorer clinical outcomes.
Abstract

Related Concept Videos

Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Sympathetic Activation01:16

Sympathetic Activation

The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...